AVIAR(MX-02) Robotic-assisted Percutaneous Coronary Intervention

NCT05981859 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2024-07-17

No results posted yet for this study

Summary

The objective of this study is to evaluate the safety and efficacy of the steerable catheter control system 'AVIAR(MX-02)', which remotely controls the guidewire and stent/balloon during the percutaneous coronary intervention (PCI) for those who have suspected coronary artery disease (CAD) and need PCI (for product approval from the MFDS).

Conditions

  • Percutaneous Coronary Intervention

Sponsors & Collaborators

  • LN Robotics

    collaborator UNKNOWN
  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Seung-Whan Lee, MD · Asan Medical Center

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-16
Primary Completion
2024-03-25
Completion
2024-04-26

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05981859 on ClinicalTrials.gov